FDA approves Moderna RSV vaccine for seniors
The FDA has accredited Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Meals and Drug Administration on Friday accredited Moderna’s vaccine for respiratory syncytial virus for adults ages 60 and above, the corporate’s second-ever product to enter the U.S. market. The choice is a win for Moderna, which desperately wants one other income supply […]